Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Vaccine Efforts Begin as Influenza A(H1N1) Begins to Spread in the United States By Denise Baez NEW YORK -- October 7, 2009 -- As vaccine doses begin to be delivered throughout the United States, widespread influenza A(H1N1) activity is being observed, according to a media briefing held on October 6 by the Centers for Disease Control and Prevention (CDC). “We’re seeing it continuing to increase in some areas; we’re seeing a slight decrease in some areas,” said Thomas Frieden, Director of the CDC, Atlanta, Georgia. “Vaccine efforts are starting and all states in the US have ordered vaccine.” The live, intranasal influenza vaccine became available on Monday, October 5, and was available to healthcare workers, children aged 2 years and older, and to healthy people who care for infants aged younger than 6 months. The injectable H1N1 vaccine will become available next week. According to Frieden, the strain that was chosen to make the vaccine continues to be an excellent match to the virus that is spreading throughout the United States, and the CDC expects a good degree of efficacy of the vaccine. He also addressed concerns that have surfaced regarding the actual manufacturing of the vaccine. Concern is that the vaccine may not be safe or that shortcuts may have taken. “The vaccine is made in the same way it’s made each year … made in the same production facilities with the same companies with the same methods.” As the vaccine makes its way throughout the United States, Frieden reiterated the 5 key groups that are to be targeted for vaccination: Pregnant women (injectable vaccine only), healthcare workers, people who care for infants aged under 6 months, children and adults aged 6 months to 24 years, and individuals aged 25 to 64 years who have underlying conditions that put them at risk for complications and/or hospitalisation from the H1N1 virus (injectable vaccine only). For individuals who wish to be vaccinated, but do not fall into 1 of the 5 target groups, waiting will be key. “We’re very confident that there will be plenty of vaccine for everyone who wants to be vaccinated,” said Frieden. “It just won’t be available when everyone wants to be vaccinated.” For now, the H1N1 virus appears to be stable. “Our biggest concern is that the virus could change and mutate to become more deadly,” said Frieden. “We have seen nothing that would be the case. So far, the virus has been quite stable genetically -- it hasn’t changed much at all.” SOURCE: Centers for Disease Control and Prevention Media Briefing E-mail this page to a friend or colleague! To print, use this version